Modified Rankin Scale Training & Certification
- Release date: October 1, 2017
- Review date: October 1, 2023
- Expiration date: September 30, 2026
- Estimated time to complete: 2.25 hours
This activity is designed to educate healthcare professionals involved in assessment of patients with stroke or other potential causes of disability so that they are better able to offer a valid and consistent (with peers) rating of their patients’ functional status for use in auditing healthcare outcomes or researching treatment efficacy and effectiveness.
- KR Lees MD
- Professor of Cerebrovascular Medicine
- University of Glasgow
This activity has been designed to meet the educational needs of physicians and nursing professionals. Other healthcare providers may also participate.
After participating in the activity, learners should be better able to:
- Rate accurately and reliably a patient’s modified Rankin Score based on the content of a brief interview with the patient or caregiver.
The modified Rankin Scale training and certification is offered as part of BlueCloud Healthcare Professional Level 2 annual membership ($89). It is also available separately ($99) on the BlueCloud Education Network.
Accreditation and Credit Designation
|| In support of improving patient care, American Academy of CME, Inc. is Jointly accredited by the Accreditation Council for Continuing Medical Education (AACME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
The American Academy of CME, Inc. is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
American Academy of CME, Inc., designates this enduring material for a maximum of 2.25 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
American Academy of CME, Inc, is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
American Academy of CME, Inc., designates this educational activity for 2.25 contact hours.
Provider approved by the California Board of Registered Nursing, Provider Number CEP16993 for [2.25] contact hours.
According to the disclosure policy of the Academy, all faculty, planning committee members, editors, managers and other individuals who are in a position to control content are required to disclose any relevant relationships with any commercial interests related to this activity. The existence of these interests or relationships is not viewed as implying bias or decreasing the value of the presentation. All educational materials are reviewed for fair balance, scientific objectivity and levels of evidence. All relevant financial relationships listed for these individuals have been mitigated. Disclosures are as follows:
K. R. Lees, MD discloses the following (not relevant to this activity): Advisory Boards: Astellas, Boehringer Ingelheim, EVER NeuroPharma, Nestlé, Novartis, Servier; Grant/Research Support: Sunovion; Speaker's Bureau: Boehringer Ingelheim (2 Lectures)
John JD Juchniewicz, MCIS, CHCP, and Natalie Kirkwood, RN, BSN, JD, American Academy of CME: No relevant financial relationships with ineligible companies.
This activity will not review off-label or investigational information.
Method of Participation
In order to receive credit and certification, learners must view the training module and correctly rate all (100%) of the patients presented to them in the certification/recertification module. After completion of the certification scenarios, learners receive feedback on the number of correctly scored patients and on whether they have met the standard required (which is based on peer performance) or should review the training materials and re-score the cases. Feedback on a case by case basis is not provided to avoid random guesswork that would undermine the validity of the final certification procedure. After achieving a passing score, learners must complete and submit the activity evaluation, which will result in a certificate of credit/certification being issued.
NOTE: Each certification is valid for up to one (1) year.
The opinions expressed in this educational activity are those of the faculty, and do not represent those of Academy or American Nurses Credentialing Center’s Commission on Accreditation. This activity is intended as a supplement to existing knowledge, published information, and guidelines. Learners should appraise the information presented critically, and draw conclusions only after careful consideration of all available scientific information. Please be advised that this training alone may not be enough to demonstrate competency or evidence based education with regulatory agencies, and additional training may be required.
NOTE TO LEARNERS:
Implicit bias refers to unconscious attitudes and stereotypes that influence our thoughts, judgements, decisions, and actions without our awareness. Everyone is susceptible to implicit bias, even clinicians. In healthcare, implicit biases can have a significant impact on the quality of care an individual receives. These biases can be both favorable and unfavorable, and are activated involuntarily without an individual’s awareness or intentional control.
It is important for healthcare professionals to recognize that their clinical decision-making may be
impacted by their own implicit biases. Considering one might have unconscious biases and exploring them may be uncomfortable because the very idea that they exist may conflict with how clinicians
perceive themselves. It is only by becoming aware of one’s unconscious biases, however, that members of the healthcare team can take steps to mitigate them to ensure all patients receive quality healthcare.
As related to Rankin and Modified Rankin scale and this test, it’s important to be aware of implicit biases as related to scoring. The Rankin Scale is a commonly used clinical tool to measure the level of disability or dependence in patients who have suffered a stroke. It is a scale ranging from 0 to 6, where 0 represents no symptoms and 6 represents death (Quinn. The modified Rankin Scale (mRS) was designed to measure poststroke recovery but is often used to describe pre-stroke disability, states Terence Quinn, the originator of the mRS.
Although currently no examples of implicit bias related directly to Rankin or mRS could be found, as you go through the training modules for this course, we encourage you to challenge yourself to look for possible implicit bias that could be unconsciously affecting how you score patients of different gender, racial or ethnic backgrounds. Whether this is the first time you are becoming certified or you have been retraining and recertifying in the Rankin or Modified Rankin Scale (mRS) for years, this course should help maintain accuracy and reliability in making Rankin or Modified Rankin Scale (mRS) assessments.
Windows Requirements: • Operating system: Windows 7 or later • Browser: Internet Explorer (10 or later), Chrome, Mozilla Firefox • Internet connection: Broadband or other high-speed connection • Flash: Adobe Flash Player 12 or later
Apple/Mac Requirements: •Operating system: Mac OS X v10.3 or later • Browser: Mozilla Firefox • Internet connection: Broadband internet connection • Flash: Adobe Flash Player 12 or later
For technical support or replacement certificates, please contact: 512-302-3113
For any questions about this activity, please contact: CEServices@academycme.org
© 2008 - Present. This CME/CNE-certified activity is held as copyrighted © by Kennedy R Lees MD. Through this notice, Kennedy R Lees MD. grant permission of its use only for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).